Scientists build mini livers to unlock genetic secrets of rare bile duct disease
NCT ID NCT06865924
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand why some people develop a rare, serious liver disease called primary sclerosing cholangitis (PSC). Researchers will create 3D cell models from patient samples to study how specific genetic changes affect bile duct cells. The goal is to find new ways to diagnose and treat the disease. About 80 adults with or without PSC will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL PRIMARY SCLEROSING CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
RECRUITINGMilan, MI, 20122, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.